Literature DB >> 20596660

Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.

Ji Un Kang1, Sun Hoe Koo, Kye Chul Kwon, Jong Woo Park.   

Abstract

Chromosomal alterations are a major genomic force contributing to the development of lung cancer. We subjected 22 cases of squamous cell carcinoma of the lung (SCC) to whole-genome microarray-CGH (resolution, 1 Mb) to identify critical genetic landmarks that might be important mediators in the formation or progression of SCC. On a genome-wide profile, copy number losses (log2 ratio <-0.25) on chromosome 9p occurred in 72.7% (16/22) of the SCC cases, and the delineated minimal common region was 9p24.3-p21.1. The progression of SCC to advanced stages or poorly differentiated malignancy was significantly associated with an increase in the copy number losses on 9p (P=0.033). More specifically, 2 distinct homozygous deletion (HD) loci (log2 ratio <-1) were identified as novel loci for candidate tumor suppressor genes (TSGs) in SCC: one, spanning 128 kbp on 9p21.1 [4.5% (1/22)] and the other, spanning approximately 200 kbp on 9p24.3 [13.6% (3/22)]. The HDs at 9p24.3 was found to contain the putative TSG, DOCK8 and 2 possible candidate TSGs, DMRT1 and DMRT3. Quantitative real-time PCR (qRT-PCR) analysis demonstrated the array-CGH-detected potential candidate genes DMRT1, DMRT3 and DOCK8, at 9p24.3 were under-expressed in SCCs. Our study indicated that chromosome 9p loss is the hallmark of SCC, and DMRT1, DMRT3 and DOCK8 genes at 9p24.3 might be of interest for the study of the pathophysiology of SCC as potential targets for therapeutic measures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596660

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

1.  Cutaneous manifestations of DOCK8 deficiency syndrome.

Authors:  Emily Y Chu; Alexandra F Freeman; Huie Jing; Edward W Cowen; Joie Davis; Helen C Su; Steven M Holland; Maria L Chanco Turner
Journal:  Arch Dermatol       Date:  2011-09-19

2.  Association between environmental tobacco smoke exposure and lung cancer susceptibility: modification by antioxidant enzyme genetic polymorphisms.

Authors:  Mona Fathy; Mai Hamed; Omnia Youssif; Nahla Fawzy; Wafa Ashour
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

Review 3.  Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.

Authors:  Helen C Su; Huie Jing; Pam Angelus; Alexandra F Freeman
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 4.  Dedicator of cytokinesis 8 (DOCK8) deficiency.

Authors:  Helen C Su
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-12

Review 5.  Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.

Authors:  Attila Kumánovics; Sherrie L Perkins; Heather Gilbert; Melissa H Cessna; Nancy H Augustine; Harry R Hill
Journal:  J Clin Immunol       Date:  2010-09-22       Impact factor: 8.317

6.  Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.

Authors:  Erin M Siegel; Steven Eschrich; Kathryn Winter; Bridget Riggs; Anders Berglund; Abidemi Ajidahun; Jeff Simko; Jennifer Moughan; Jaffer Ajani; Anthony Magliocco; Abul Elahi; Sarah Hoffe; David Shibata
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

7.  Proteogenomic analysis of human chromosome 9-encoded genes from human samples and lung cancer tissues.

Authors:  Jung-Mo Ahn; Min-Sik Kim; Yong-In Kim; Seul-Ki Jeong; Hyoung-Joo Lee; Sun Hee Lee; Young-Ki Paik; Akhilesh Pandey; Je-Yoel Cho
Journal:  J Proteome Res       Date:  2013-12-06       Impact factor: 4.466

8.  A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.

Authors:  Xu Guo; Xi Ma; Jiaze An; Yukui Shang; Qichao Huang; Hushan Yang; Zhinan Chen; Jinliang Xing
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

9.  Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung.

Authors:  Jiun Kang
Journal:  Exp Ther Med       Date:  2014-12-09       Impact factor: 2.447

10.  Comparative analysis of methods for identifying recurrent copy number alterations in cancer.

Authors:  Xiguo Yuan; Junying Zhang; Shengli Zhang; Guoqiang Yu; Yue Wang
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.